526 filings
8-K
BPTH
Bio-Path Holdings Inc
15 May 24
Bio-Path Holdings Reports First Quarter 2024 Financial Results
7:10am
10-Q
2024 Q1
BPTH
Bio-Path Holdings Inc
Quarterly report
14 May 24
4:10pm
EFFECT
BPTH
Bio-Path Holdings Inc
3 May 24
Notice of effectiveness
12:15am
D
BPTH
Bio-Path Holdings Inc
25 Apr 24
$1.28 mm in options / securities to be acquired, sold $1.28 mm, 3 investors
6:04pm
S-1
BPTH
Bio-Path Holdings Inc
IPO registration
24 Apr 24
4:35pm
8-K
k3ooczha owbjdm
19 Apr 24
Other Events
3:31pm
424B5
x236 k4zzzg4y1ze3zld
19 Apr 24
Prospectus supplement for primary offering
3:28pm
8-K
804gnx4fgi940zif
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
424B5
0hcyfl1 gh
19 Apr 24
Prospectus supplement for primary offering
9:17am
8-K
rzwb5m6adir9 wzmjk
18 Apr 24
Other Events
9:13am
8-K
tqivi0n2tlubt wxs
15 Apr 24
Bio-Path Holdings Expands Global Patent Portfolio
7:30am
D
3e41on806vs5s
5 Apr 24
$317.93 k in options / securities to be acquired, sold $317.93 k, 1 investor
4:01pm
8-K
ayl32q2 c1yp8h7gd6s5
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
424B5
8fr582fhrg0fq6yd5h98
4 Apr 24
Prospectus supplement for primary offering
4:33pm
8-K
e6xtgsu9c4ydin
2 Apr 24
Bio-Path Holdings Provides 2024 Clinical and Operational Update
4:10pm
8-K
c22ra9p9j m4fcpt1ns
27 Mar 24
Other Events
8:20am
424B5
ykp5siz2 by155
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
jmcs4z9yf9nk pnrfd0c
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
RW
a28shmpb5z5cd3k
25 Mar 24
Registration withdrawal request
10:00am
8-K
uifdbul
13 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm